Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v12-FR Version v3-EN
Language French English
Date Updated 2019-01-14 2018-11-29
Drug Identification Number 02018160 02018160
Brand name CYCLOMEN CYCLOMEN
Common or Proper name Cyclomen 200mg Cyclomen 200mg
Company Name SANOFI-AVENTIS CANADA INC SANOFI-AVENTIS CANADA INC
Ingredients DANAZOL DANAZOL
Strength(s) 200MG 200MG
Dosage form(s) CAPSULE CAPSULE
Route of administration ORAL ORAL
Packaging size 100'S 100'S
ATC code G03XA G03XA
ATC description OTHER SEX HORM. & MODULATORS OF THE GENITAL SYSTEM OTHER SEX HORM. & MODULATORS OF THE GENITAL SYSTEM
Reason for shortage Other (Please describe in comments) Other (Please describe in comments)
Anticipated start date
Actual start date 2018-11-15 2018-11-15
Estimated end date 2019-01-09 2018-12-14
Actual end date 2019-01-09
Shortage status Resolved Actual shortage
Company comments The anticipated availability date represents estimated availability at the main Sanofi warehouse. Availability dates at a customer’s usual distributor warehouse may vary. Pharmacies are invited to communicate with their preferred distributor to obtain the product availability date. Patients should validate the availability of the product with their respective pharmacy. Delay in production
Health Canada comments